ImmPACT Bio
Transformative CAR T-cell therapies
About ImmPACT Bio
ImmPACT Bio USA, Inc. is a clinical-stage company dedicated to discovering transformative chimeric antigen receptor (CAR) T-cell therapies for cancer and autoimmune diseases. Our technology precisely distinguishes cancer and diseased cells from normal cells, eliminating them without damaging normal tissues. Founded in 2017 in Israel and incorporated in the US in 2019, ImmPACT Bio merged with Kalthera in 2021 and moved to West Hills, CA in 2022, where we built a state-of-the-art clinical manufacturing facility.
Benefits of using Remote First Jobs
Discover Hidden Jobs
Unique jobs you won't find on other job boards.
Advanced Filters
Filter by category, benefits, seniority, and more.
Priority Job Alerts
Get timely alerts for new job openings every day.
Manage Your Job Hunt
Save jobs you like and keep a simple list of your applications.
Search remote, work from home, 100% online jobs
We help you connect with top remote-first companies.
Hiring remote talent? Post a job